Phylex BioSciences Accelerates Hantavirus Vaccine Development Using AI Technology#USA#Del_Mar#mRNA_Technology#Phylex_BioSciences#Andes_hantavirus
Phylex BioSciences Accelerates Hantavirus Vaccine Development Using AI Technology
Phylex BioSciences swiftly develops an AI-derived mRNA nanoparticle vaccine targeting the Andes hantavirus, demonstrating rapid response capabilities.
third-news.com
May 13, 2026 at 7:52 PM
Phylex BioSciences Accelerates Hantavirus Vaccine Development Using AI Technology#USA#Del_Mar#mRNA_Technology#Phylex_BioSciences#Andes_hantavirus